Griseofulvin is the oral antifungal agent of choice for the treatment of dermatophytoses. This article reviews the history, pharmacokinetics, adverse reactions traditional therapeutic applications of griseofulvin. In addition, reports since 1960 of the use of the drug in the treatment of Raynaud's phenomenon, progressive systemic sclerosis, lichen planus, mycosis fungoides, herpes zoster, eosinophilic fasciitis molluscum contagiosum are discussed, noting the varying degree of therapeutic success.
Get full access to this article
View all access options for this article.
References
1.
OxfordAERaistrickHSimonartP. Griseofulvin, C17H17O6Cl, a metabolic product of Pennicillium Griseo-fulvum Dierckx. Biochem J1939; 33: 240–8.
2.
AndersonDW. Griseofulvin: Biology and clinical usefulness. Ann Allergy1965; 23: 103–10.
3.
GentlesJC. Experimental ringworm in guinea pigs: Oral treatment with griseofulvin. Nature1958; 182: 476–7.
McEvoyGK, ed. Drug information 88. Bethesda, MD: American Society of Hospital Pharmacists, 1988: 76–8.
6.
LinC-CMagatJChangRMcGlottenJSymchowiczS. Absorption, metabolism and excretion of 14C-griseofulvin in man. J Pharmacol Exp Ther1973; 187: 415–22.
7.
StraughnABMeyerMCRaghowGRotenbergK. Bioavailability of microsize and ultramicrosize griseofulvin products in man. J Pharmacokinet Biopharm1980; 8: 347–62.
8.
BlankH. Commentary: Treatment of dermatomycoses with griseofulvin. Arch Dermatol1982; 118: 834–6.
HayRJClaytonYMGriffithsWADDowdPM. A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis. Br J Dermatol1985; 112: 691–6.
11.
HayRJClaytonYMMooreMK. A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol1987; 12: 175–7.
SabriSRobertsVCHigginsRFCottonLTWilliamsDIWilsonLC. A double-blind clinical trial of griseofulvin in patients with Raynaud's phenomenon. Postgrad Med J1973; 49: 641–3.
SehgalVNBikhchandaniRKoranneRVNayarMSaxenaHMK. Histopathological evaluation of griseofulvin therapy in lichen planus, a double-blind controlled study. Dermatologica1980; 161: 22–7.
16.
LevyAStemplerDYuzukSSchewach-MjlletMRonenM. Communication: Treatment of lichen planus with griseofulvin (letter). Int J Dermatol1986; 25: 405.
17.
BaganJVSilvestreFJMestreSGisbertCBermejoAAgramuntJ. Treatment of lichen planus with griseofulvin; report of seven cases. Oral Surg Med Oral Pathol1985; 60: 608–10.
18.
ShelleyWB. Demethylchlortetracycline and griseofulvin as examples of specific treatment for mycosis fungoides. Br J Dermatol1981; 104: 477–80.
19.
ThomsenK. Correspondence: Mycosis fungoides responding to tetracycline and griseofulvin (letter). Br J Dermatol1981; 105: 483–4.
20.
JoubertJD. Correspondence: Griseofulvin in the treatment of herpes zoster (letter). S Afr Med J1978; 54 (6):224.
21.
CastelliMZancaAGiubertoniGZancaABertoliniA. Griseofulvin-methisoprinol combination in the treatment of herpes zoster. Pharmacol Res Commun1986; 18: 991–6.
